CCES 2022 CCES vs Jessica Pietrzyk

In April 2022 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the powerlifter Jessica Pietrzyk after her sample tested positive for the prohibited substances Metandienone, Methylphenidate. After a notification a provisional suspension was ordered.

Hereafter CCES establishes that the Athlete had failed to dispute the asserted anti-doping rule violation within the set deadline. Accordingly the CCES finds that the Athlete is deemed to have admitted the asserted violation, waived her right to a hearing and accepted all proposed consequences.

Therefore the CCES decides on 13 May 2022 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 4 April 2022.

Original document

Parameters

Legal Source
National Decisions
Date
13 May 2022
Original Source
Canadian Centre for Ethics in Sport (CCES)
Country
Canada
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Admission
Substantial delay / lapsed time limit
Waiver of "right to be heard"
Sport/IFs
Powerlifting (IPF) - International Powerlifting Federation
Other organisations
Canadian Centre for Ethics in Sport (CCES)
Laboratories
Montreal, Canada: Laboratoire de controle du dopage INRS-Institut Armand-Frappier
Doping classes
S1. Anabolic Agents
S6. Stimulants
Substances
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Methylphenidate
Document type
Pdf file
Date generated
26 April 2022
Date of last modification
20 July 2023
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin